Earnings History Data for T2 Biosystems, Inc. (TTOO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
T2 Biosystems, Inc.
T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14-11-2024 | AH | TTOO | T2 Biosystems, Inc. | 9.16 | -0.57 | 0.00 | -3.45 | T2 Biosystems GAAP EPS of -$0.57, revenue of $1.99M [11/14/2024 4:07 PM] |
0.5040 | -0.02 (-3.08%) |
0.49 | -0.03 (-6.02%) |
0.44 - 8.38 | 813,102 | 830,000 | 204,973 | ||
|
||||||||||||||||||
29-07-2024 | AH | TTOO | T2 Biosystems, Inc. | 42.47 | -0.66 | 0.00 | 8.00 | T2 Biosystems GAAP EPS of -$0.66 beats by $0.31, revenue of $1.95M misses by $0.15M [7/29/2024 4:06 PM] |
4.87 | 0.13 (2.74%) |
5.11 | 0.37 (7.81%) |
2.60 - 70.00 | 195,193 | 100,000 | 39,903 | ||
06-05-2024 | AH | TTOO | T2 Biosystems, Inc. | 20.12 | -2.66 | 0.00 | -99.99 | T2 Biosystems GAAP EPS of -$2.66, revenue of $2.06M [5/6/2024 4:39 PM] |
3.25 | -0.38 (-10.61%) |
3.85 | 0.22 (6.06%) |
2.60 - 70.00 | 684,385 | 370,000 | 97,646 | ||
15-02-2024 | AH | TTOO | T2 Biosystems, Inc. | 25.27 | N/A | 0.00 | 0.00 | T2 Biosystems reports Q4 results [2/15/2024 4:10 PM] |
5.41 | -0.98 (-15.41%) |
5.89 | -0.50 (-7.82%) |
3.36 - 89.00 | 313,818 | 720,000 | 23,068 | ||
07-08-2023 | AH | TTOO | T2 Biosystems, Inc. | 8.71 | -0.08 | 0.00 | 5.00 | T2 Biosystems GAAP EPS of -$0.08 beats by $0.19, revenue of $1.96M misses by $0.04M [8/7/2023 4:15 PM] |
0.3064 | 0.06 (25.21%) |
0.26 | 0.01 (5.48%) |
0.05 - 15.00 | 184,396,217 | 158,860,000 | 12,952,650 | ||
23-05-2023 | PM | Before the open (May 22) |
TTOO | T2 Biosystems, Inc. | 5.56 | -1.17 | 0.00 | 5.00 | T2 Biosystems GAAP EPS of -$1.32 misses by $0.07, revenue of $2.1M misses by $0.23M [5/23/2023 8:13 AM] |
0.1690 | -0.11 (-40.24%) |
0.27 | -0.01 (-5.27%) |
0.17 - 15.00 | 12,933,282 | 650,000 | 174,672 | |
13-03-2023 | AH | 4:05 PM ET (Mar 13) |
TTOO | T2 Biosystems, Inc. | 10.09 | N/A | 0.00 | -3.50 | T2 Biosystems GAAP EPS of -$1.41 beats by $0.92, revenue of $5.48M beats by $0.08M [3/13/2023 4:07 PM] |
0.5650 | -0.02 (-2.74%) |
0.58 | 0.0 (0.43%) |
0.54 - 29.25 | 267,163 | 380,000 | 14,510 | |
10-11-2022 | AH | 4:05 PM ET (Nov 10) |
TTOO | T2 Biosystems, Inc. | 12.83 | -2.95 | 0.00 | 4.00 | T2 Biosystems GAAP EPS of -$2.95 misses by $0.90, revenue of $3.68M misses by $1.05M [11/10/2022 4:10 PM] |
1.90 | 0.05 (2.70%) |
1.79 | -0.06 (-3.24%) |
1.55 - 37.44 | 349,930 | 110,000 | 776 | |
|
||||||||||||||||||
15-08-2022 | AH | 4:05 PM ET (Aug 15) |
TTOO | T2 Biosystems, Inc. | 23.58 | -0.10 | 0.00 | -0.08 | T2 Biosystems GAAP EPS of -$0.10 misses by $0.01, revenue of $5.91M misses by $0.22M [8/15/2022 4:06 PM] |
0.1609 | -0.04 (-21.59%) |
0.17 | -0.04 (-17.59%) |
0.11 - 1.12 | 91,266,765 | 150,070,000 | 8,055,548 | |
05-05-2022 | AH | 4:05 PM ET (May 5) |
TTOO | T2 Biosystems, Inc. | 67.34 | -0.10 | 0.00 | -0.07 | T2 Biosystems GAAP EPS of -$0.10 misses by $0.02, revenue of $7.23M beats by $0.53M [5/5/2022 4:24 PM] |
0.3030 | -0.08 (-21.38%) |
0.36 | -0.03 (-6.62%) |
0.30 - 1.48 | 3,050,887 | 970,000 | 174,744 | |
|
||||||||||||||||||
17-02-2022 | AH | 4:05 PM ET (Feb 17) |
TTOO | T2 Biosystems, Inc. | 66.79 | -0.07 | 0.00 | -0.07 | T2 Biosystems GAAP EPS of -$0.07 beats by $0.03, revenue of $6.98M beats by $1.58M [2/17/2022 4:07 PM] |
0.4709 | 0.07 (16.99%) |
0.46 | 0.05 (13.04%) |
0.35 - 3.12 | 5,123,556 | 1,610,000 | 211,427 | |
04-11-2021 | AH | 4:05 PM ET (Nov 4) |
TTOO | T2 Biosystems, Inc. | 133.19 | -0.08 | 0.00 | -0.08 | T2 Biosystems EPS beats by $0.01, beats on revenue [11/4/2021 4:26 PM] |
0.7851 | -0.03 (-3.92%) |
0.83 | 0.01 (1.58%) |
0.76 - 3.79 | 4,695,281 | 3,360,000 | 126,099 | |
|
||||||||||||||||||
05-08-2021 | AH | 4:05 PM ET (Aug 5) |
TTOO | T2 Biosystems, Inc. | 154.61 | -0.08 | -0.08 | -0.09 | T2 Biosystems EPS in-line, beats on revenue [8/5/2021 4:10 PM] |
1.05 | -0.11 (-9.83%) |
1.11 | -0.06 (-5.13%) |
1.00 - 3.79 | 4,919,095 | 3,940,000 | 91,744 | |
06-05-2021 | AH | 4:05 PM ET (May 6) |
TTOO | T2 Biosystems, Inc. | 204.92 | -0.07 | -0.07 | -0.22 | T2 Biosystems reports Q1 results [5/6/2021 4:11 PM] |
1.19 | 0.03 (2.59%) |
1.27 | 0.11 (9.48%) |
0.48 - 3.79 | 12,468,264 | 2,810,000 | 2,245,361 | |
|
||||||||||||||||||
04-03-2021 | AH | 4:05 PM ET (Mar 4) |
TTOO | T2 Biosystems, Inc. | 338.82 | -0.07 | -0.06 | -0.30 | T2 Biosystems EPS in-line, misses on revenue [3/4/2021 4:11 PM] |
1.60 | -0.34 (-17.69%) |
1.84 | -0.11 (-5.64%) |
0.24 - 3.79 | 22,225,536 | 7,596,246 | 615,373 | |
04-11-2020 | AH | 4:05 PM ET (Nov 4) |
TTOO | T2 Biosystems, Inc. | 195.29 | -0.08 | -0.10 | -0.31 | T2 Biosystems EPS in-line, beats on revenue [11/4/2020 4:11 PM] |
1.31 | -0.20 (-13.24%) |
1.31 | -0.20 (-13.24%) |
0.24 - 3.00 | 8,034,206 | 3,979,113 | 375,553 | |
|
||||||||||||||||||
11-08-2020 | AH | 4:05 PM ET (Aug 11) |
TTOO | T2 Biosystems, Inc. | 203.21 | -0.09 | -0.18 | -0.35 | T2 Biosystems EPS beats by $0.05, revenue in-line [8/11/2020 4:07 PM] |
1.56 | -0.31 (-16.58%) |
1.72 | -0.15 (-8.02%) |
0.24 - 3.21 | 10,135,113 | 13,370,882 | 924,996 | |
|
||||||||||||||||||
05-05-2020 | AH | 4:05 PM ET (May 5) |
TTOO | T2 Biosystems, Inc. | 64.26 | -0.22 | -0.28 | -0.34 | T2 Biosystems EPS beats by $0.02, beats on revenue [5/5/2020 4:27 PM] |
0.5956 | 0.01 (2.50%) |
0.5650 | -0.03 (-5.14%) |
0.24 - 3.21 | 8,211,991 | 4,464,051 | 722,714 | |
|